Search Results 231-240 of 16628 for anti-TNF drugs

1. Interferon alfa-2b (injection route) - Side effects & uses - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. R-3750 in Patients With Mild to Moderate Ulcerative Colitis - Mayo Clinic

   Treatment with immunosuppressants or anti-cancer drugs; e.g., anti-TNF-α agents, anti-integrin agents, azathioprine or 6-MP, 6-thioguanine, methotrexate ...

3. A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma - Mayo Clinic

   About this study. This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called ...

4. Emerging treatments for multiple sclerosis - Mayo Clinic

   The majority of DMTs approved by the U.S. Food and Drug Administration (FDA) are effective at helping to manage relapsing-remitting MS. This form of MS affects ...

5. Drugs and Supplements that Start with L - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “L” to learn about drug side effects, proper use and ...

6. Tocilizumab-anoh (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Tocilizumab-anoh injection is used alone or together with other medicines to treat moderate to severe active rheumatoid arthritis in patients who have been ...

7. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Subject who received nonsteroidal anti-inflammatory drugs (NSAIDs) within 7 days prior to Baseline, except topical NSAIDs and low dose aspirin for ...

8. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... TNF inhibitors within 2-8 weeks of or 5 half-lives (etanercept ...

9. An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors - Mayo Clinic

   An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid ...

10. Ustekinumab-aekn (subcutaneous route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...